These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 19883640

  • 1. Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh.
    Choi EY, Chang W, Lim S, Song BW, Cha MJ, Kim HJ, Choi E, Jang Y, Chung N, Hwang KC.
    Eur J Pharmacol; 2010 Feb 10; 627(1-3):56-62. PubMed ID: 19883640
    [Abstract] [Full Text] [Related]

  • 2. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
    Kang BY, Mehta JL.
    J Cardiovasc Pharmacol Ther; 2009 Dec 10; 14(4):283-91. PubMed ID: 19724024
    [Abstract] [Full Text] [Related]

  • 3. Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats.
    Xu X, Zhang L, Liang J.
    Mol Med Rep; 2013 Aug 10; 8(2):385-92. PubMed ID: 23799547
    [Abstract] [Full Text] [Related]

  • 4. Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.
    Custodis F, Eberl M, Kilter H, Böhm M, Laufs U.
    Cardiovasc Res; 2006 Jul 15; 71(2):342-51. PubMed ID: 16698001
    [Abstract] [Full Text] [Related]

  • 5. G(alphaq)-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates cardiac hypertrophy in vitro and in vivo.
    Zhang HG, Li XH, Zhou JZ, Liu Y, Jia Y, Yuan ZB.
    Clin Exp Pharmacol Physiol; 2007 Dec 15; 34(12):1276-81. PubMed ID: 17973867
    [Abstract] [Full Text] [Related]

  • 6. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y, Miyauchi T, Sakai S, Kasuya Y, Ogata T, Takanashi M, Iemitsu M, Sudo T, Goto K, Yamaguchi I.
    Circulation; 2004 Feb 24; 109(7):904-10. PubMed ID: 14967736
    [Abstract] [Full Text] [Related]

  • 7. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K, Adachi S, Maejima Y, Tamamori-Adachi M, Suzuki J, Kitajima S, Ito H, Isobe M.
    Life Sci; 2006 Aug 29; 79(14):1380-90. PubMed ID: 16712874
    [Abstract] [Full Text] [Related]

  • 8. The 1,4,5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes.
    Barac YD, Zeevi-Levin N, Yaniv G, Reiter I, Milman F, Shilkrut M, Coleman R, Abassi Z, Binah O.
    Cardiovasc Res; 2005 Oct 01; 68(1):75-86. PubMed ID: 16005448
    [Abstract] [Full Text] [Related]

  • 9. Norepinephrine-induced changes in gene expression of phospholipase C in cardiomyocytes.
    Singal T, Dhalla NS, Tappia PS.
    J Mol Cell Cardiol; 2006 Jul 01; 41(1):126-37. PubMed ID: 16714034
    [Abstract] [Full Text] [Related]

  • 10. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F, Könemann S, Wolff B, Barth S, Staudt A, Kroemer HK, Dahm JB, Felix SB, Landsberger M.
    J Physiol Pharmacol; 2007 Sep 01; 58(3):503-14. PubMed ID: 17928646
    [Abstract] [Full Text] [Related]

  • 11. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.
    Cheng TH, Shih NL, Chen CH, Lin H, Liu JC, Chao HH, Liou JY, Chen YL, Tsai HW, Chen YS, Cheng CF, Chen JJ.
    J Biomed Sci; 2005 Sep 01; 12(1):123-33. PubMed ID: 15864745
    [Abstract] [Full Text] [Related]

  • 12. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H, Shi S, Sun YH, Zhao YJ, Li QF, Li HZ, Wang R, Xu CQ.
    Clin Exp Pharmacol Physiol; 2009 Mar 01; 36(3):312-8. PubMed ID: 18986329
    [Abstract] [Full Text] [Related]

  • 13. Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes.
    Vlasblom R, Muller A, Musters RJ, Zuidwijk MJ, Van Hardeveld C, Paulus WJ, Simonides WS.
    Cardiovasc Res; 2004 Aug 15; 63(3):537-44. PubMed ID: 15276479
    [Abstract] [Full Text] [Related]

  • 14. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
    Lu YM, Shioda N, Han F, Kamata A, Shirasaki Y, Qin ZH, Fukunaga K.
    Cardiovasc Ther; 2009 Aug 15; 27(1):17-27. PubMed ID: 19207476
    [Abstract] [Full Text] [Related]

  • 15. A farnesyltransferase inhibitor attenuates cardiac myocyte hypertrophy and gene expression.
    Calderone A, Abdelaziz N, Colombo F, Schreiber KL, Rindt H.
    J Mol Cell Cardiol; 2000 Jun 15; 32(6):1127-40. PubMed ID: 10888263
    [Abstract] [Full Text] [Related]

  • 16. Deletion of the inducible 70-kDa heat shock protein genes in mice impairs cardiac contractile function and calcium handling associated with hypertrophy.
    Kim YK, Suarez J, Hu Y, McDonough PM, Boer C, Dix DJ, Dillmann WH.
    Circulation; 2006 Jun 06; 113(22):2589-97. PubMed ID: 16735677
    [Abstract] [Full Text] [Related]

  • 17. Impact of HMG CoA reductase inhibition on small GTPases in the heart.
    Laufs U, Kilter H, Konkol C, Wassmann S, Böhm M, Nickenig G.
    Cardiovasc Res; 2002 Mar 06; 53(4):911-20. PubMed ID: 11922901
    [Abstract] [Full Text] [Related]

  • 18. Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells.
    Kim YS, Ahn Y, Hong MH, Kim KH, Park HW, Hong YJ, Kim JH, Kim W, Jeong MH, Cho JG, Park JC, Kang JC.
    J Cardiovasc Pharmacol; 2007 Jun 06; 49(6):376-83. PubMed ID: 17577102
    [Abstract] [Full Text] [Related]

  • 19. PKC mediates cyclic stretch-induced cardiac hypertrophy through Rho family GTPases and mitogen-activated protein kinases in cardiomyocytes.
    Pan J, Singh US, Takahashi T, Oka Y, Palm-Leis A, Herbelin BS, Baker KM.
    J Cell Physiol; 2005 Feb 06; 202(2):536-53. PubMed ID: 15316932
    [Abstract] [Full Text] [Related]

  • 20. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
    Zhou DX, Liang QS, He XX, Zhan CY.
    Zhongguo Zhong Yao Za Zhi; 2008 Apr 06; 33(8):936-9. PubMed ID: 18619357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.